AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company.
Global 500, is an annual ranking of the top 500 corporations worldwide
Global 500Top 100 largest companies in Russia by revenue
Top 100Local legal entities in Russia: AstraZeneca Pharmaceuticals LLC and and AstraZeneca Industries LLC. The Anglo-Swedish biopharmaceutical company AstraZeneca has presented its report for 2024. The company’s total revenue increased by 21% last year, reaching $54.07 billion. The growth was due, among other things, to a 19% increase in sales, as well as increased cooperation in the field of drug production. Revenues and profits of OOO AstraZeneca Industries (the company’s Russian plant) also increased significantly. It showed the highest net profit since 2015, when the plant was launched in the Kaluga region.
The company promised to stop new investments in Russia. It is continuing to work in Russia, and are taking all required measures to ensure an uninterrupted supply of medicines. Despite the statements of international pharmaceutical companies about the suspension of new tests in Russia after the start of military operations in Ukraine, the British-Swedish AstraZeneca will conduct a study of a new drug for the prevention of COVID-19 in the Russian Federation, which is necessary before its registration. AstraZeneca has spent about £45 million to pay Russian doctors since Moscow invaded and its chief said ‘medicines are never under sanctions’. AstraZeneca was the main sponsor of a major summit on bringing European businesses back to Russia - the 21st Association of European Businesses in Russia event. Revenue increased in 2024 vs 2023 by more than +30%.